Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 121 | IDYA | IDEAYA BIOSCIENCES INC | Healthcare | 11,290.0 | $421K | 0.10% | +3K | +40.9% | $37.27 | +1.0% |
| 122 | ZBIO | ZENAS BIOPHARMA INC | Healthcare | 16,525.0 | $419K | 0.10% | +10K | +146.0% | $25.38 | +25.8% |
| 123 | OLMA | OLEMA PHARMACEUTICALS INC | Healthcare | 33,150.0 | $415K | 0.10% | +25K | +301.8% | $12.51 | -21.8% |
| 124 | — | PRAXIS PRECISION MEDICINES I | — | 1,227.0 | $411K | 0.10% | +214.0 | +21.1% | $334.79 | — |
| 125 | VERA | VERA THERAPEUTICS INC | Healthcare | 9,550.0 | $410K | 0.10% | +4K | +74.5% | $42.91 | -21.5% |
| 126 | GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | 7,622.0 | $409K | 0.10% | +4K | +87.5% | $53.67 | -27.4% |
| 127 | REPL | REPLIMUNE GROUP INC | Healthcare | 36,846.0 | $408K | 0.10% | +10K | +37.6% | $11.07 | +17.7% |
| 128 | CTMX | CYTOMX THERAPEUTICS INC. | Healthcare | 108,703.0 | $408K | 0.10% | +44K | +67.0% | $3.75 | -28.3% |
| 129 | SRRK | SCHOLAR ROCK HLDG CORP | Healthcare | 7,406.0 | $407K | 0.10% | +2K | +27.3% | $55.00 | -9.1% |
| 130 | PROK | PROKIDNEY CORP | Healthcare | 199,510.0 | $407K | 0.10% | +76K | +61.7% | $2.04 | -14.7% |
| 131 | RCKT | ROCKET PHARMACEUTICALS INC | Healthcare | 118,981.0 | $407K | 0.10% | +39K | +47.9% | $3.42 | -0.3% |
| 132 | MAZE | MAZE THERAPEUTICS INC | Healthcare | 13,605.0 | $406K | 0.10% | +7K | +93.9% | $29.84 | -18.8% |
| 133 | AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | 22,426.0 | $403K | 0.09% | +2K | +7.7% | $17.96 | +84.6% |
| 134 | PCVX | VAXCYTE INC | Healthcare | 6,894.0 | $401K | 0.09% | +768.0 | +12.5% | $58.13 | +1.9% |
| 135 | SION | SIONNA THERAPEUTICS INC | Healthcare | 9,109.0 | $401K | 0.09% | +3K | +42.9% | $43.99 | -84.4% |
| 136 | DYN | DYNE THERAPEUTICS INC | Healthcare | 17,988.0 | $400K | 0.09% | +4K | +27.1% | $22.21 | -19.4% |
| 137 | ANNX | ANNEXON INC | Healthcare | 69,468.0 | $397K | 0.09% | +15K | +26.6% | $5.71 | -31.3% |
| 138 | — | ASSEMBLY BIOSCIENCES INC | — | 14,251.0 | $392K | 0.09% | +7K | +88.7% | $27.48 | — |
| 139 | TSHA | TAYSHA GENE THERAPIES INC | Healthcare | 57,303.0 | $390K | 0.09% | +10K | +21.7% | $6.81 | -25.7% |
| 140 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 10,464.0 | $389K | 0.09% | +553.0 | +5.6% | $37.21 | +3.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
36.7%
Technology
15.7%
Financial Services
15.2%
Industrials
13.0%
Consumer Cyclical
5.8%
Energy
4.7%
Real Estate
2.8%
Utilities
1.7%
Communication Services
1.7%
Basic Materials
1.5%